8 insiders reported 28 Form 4 transactions for Akari Therapeutics Plc (AKTX) over the past 18 months (most recent 2026-06-25). Recent activity: Farag Kameel D. (Interim CFO) Buy 1,248 shares, Farag Kameel D. (Interim CFO) Buy 1,395 shares, Farag Kameel D. (Interim CFO) Buy 1,570 shares, Farag Kameel D. (Interim CFO) Buy 2,539 shares, Farag Kameel D. (Interim CFO) Buy 3,725 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 1,248 | $12,505 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 1,395 | $13,001 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 1,570 | $13,000 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 2,539 | $13,000 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 3,725 | $13,000 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 7,353 | $27,500 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | Buy | 1,000 | $13,000 |
| 2025-11-04 | Farag Kameel D. | Interim CFO | Buy | 32,000 | $24,000 |
| 2025-11-04 | Farag Kameel D. | Interim CFO | Buy | 26,619 | $19,964 |
| 2025-10-24 | Farag Kameel D. | Interim CFO | Buy | 6,277 | $4,645 |
| 2025-08-29 | Gaslightwala Abizer | CEO | Buy | 3,000 | $0 |
| 2025-08-29 | Gaslightwala Abizer | CEO | Buy | 8,000 | $0 |
| 2025-08-29 | Gaslightwala Abizer | CEO | Buy | 10,000 | $0 |
| 2025-06-25 | Gaslightwala Abizer | President & CEO | Buy | 943 | $0 |
| 2025-06-25 | Gaslightwala Abizer | President & CEO | Buy | 5,203 | $0 |
| 2025-06-24 | Gaslightwala Abizer | President & CEO | Buy | 10,000 | $0 |
| 2025-06-20 | Gaslightwala Abizer | President & CEO | Buy | 15,000 | $0 |
| 2025-06-16 | Gaslightwala Abizer | CEO | Buy | 20,000 | $24,600 |
| 2025-06-16 | Gaslightwala Abizer | CEO | Buy | 25,000 | $29,750 |
| 2025-06-12 | Gaslightwala Abizer | CEO | Buy | 20,000 | $25,400 |
| 2025-04-29 | Patel Sandip I | Director | Buy | 44,642 | $49,999 |
| 2025-03-10 | Huh Hoyoung | Director | Buy | 892,857 | $1,000,000 |
| 2025-03-10 | Patel Samir Rashmikant | Director | Buy | 406,250 | $455,000 |
| 2025-03-10 | Neal James R | Director | Buy | 4,464 | $5,000 |
| 2025-03-10 | Prudo-Chlebosz Raymond | Director | Buy | 446,428 | $499,999 |
Source: SEC Form 4 filings · as of 2026-06-25